DND Pharmatech Inc (347850) Stock Price & News

Why is 347850 down 2.51%?

Dive Deeper

347850:KOSDAQ

DND Pharmatech Inc

₩40,700.00

-2.51%

(-1,050.00) 1D

Nov 13, 3:30:05 PM GMT+9 · KRW

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 347850...

Open

₩42,100

High

₩44,300

Low

₩40,500

Mkt. cap

1.87T

Avg. vol.

572.12K

Volume

622.48K

52-wk high

₩116,600

52-wk low

₩34,500

EPS

-₩494

Shares outstanding

46.00M

No. of employees

Open

₩42,100

High

₩44,300

Low

₩40,500

Mkt. cap

1.87T

Avg. vol.

572.12K

Volume

622.48K

52-wk high

₩116,600

52-wk low

₩34,500

EPS

-₩494

Shares outstanding

46.00M

No. of employees

Related stocks

226950

OliX Pharmaceuticals Inc

LigaChem Biosciences Inc

News stories

From web sources and news partners

The Korea Times

58 minutes ago

Stocks sway as Wall Street heads for winning week after several turbulent days

24/7 Wall St.

14 minutes ago

The S&P 500 Has a "Pure Value" Version. RPV Gives Its Cheapest Stocks the Biggest Weights

FOREX.com

5 hours ago

S&P 500 forecast: SPX struggles for direction ahead of PPI data

BigGo Finance

8 hours ago

Goldman Sachs Sees S&P 500 Hitting 8,700 by End of Next Year; Japan Stocks Also Overweight, TOPIX Target 4,500

About DND Pharmatech Inc

CEO-

Employees25

Founded2014

Headquarters-

SectorHealth Care

IndustryBiotechnology

Websiteddpharmatech.com

All values in KRW	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	969.49M	990.09M	128.78M	662.06M
Cost of goods sold	5.33M	5.58M	5.98M	5.99M
Cost of revenue	5.33M	5.58M	5.98M	5.99M
Research and development expenses	4.87B	7.21B	6.73B	6.36B
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	993.83M	2.80B	2.93B	2.65B
Operating expense	7.17B	11.40B	11.24B	10.54B
Total operating expenses	7.18B	11.40B	11.25B	10.54B
Operating income	-6.21B	-10.41B	-11.12B	-9.88B
Other non operating income	1.27B	13.17B	1.44B	5.31B
EBT including unusual items	-5.98B	1.62B	-10.32B	-8.01B
EBT excluding unusual items	-5.98B	1.62B	-10.30B	-8.01B
Income tax expense	-223.97M	-234.99M	-237.36M	-243.42M
Effective tax rate	3.75%	-14.54%	2.30%	3.04%
Other operating expenses	167.06M	243.12M	394.40M	188.38M
Net income	-5.64B	1.81B	-9.50B	-8.27B
Net profit margin	-582.17%	182.60%	-7,373.87%	-1,249.54%
Earnings per share	-	-	-	-
Interest and investment income	249.94M	226.94M	197.28M	1.36B
Interest expense	-98.58M	-96.17M	-90.29M	-2.81B
Net interest expenses	151.36M	130.77M	106.99M	-1.45B
Depreciation and amortization charges	315.43M	274.48M	319.62M	430.94M
EBITDA	-4.85B	-9.05B	-9.72B	-8.33B
Gain or loss from assets sale	119.00K	-1.00K	21.90M	279.00K

Ask anything